MSTT1041A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MSTT1041A, covering 2022-12-28 to 2023-05-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis [Phase 2]